Login / Signup

Analysis of response-related endpoints in trials of first-line medical treatment of metastatic colorectal cancer.

Giuseppe Antonio CollocaAntonella VenturinoDomenico Guarneri
Published in: International journal of clinical oncology (2019)
The results of the present trial-level analysis report a good performance of two response-related endpoints, DCR and ETS, and suggest that they could be differently used depending on the setting of disease and the type of medical treatment.
Keyphrases
  • healthcare
  • metastatic colorectal cancer
  • clinical trial
  • transcription factor
  • randomized controlled trial
  • phase ii
  • open label